NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Resverlogix


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


 Refine Search
Display Mode: Context | Summary
Resverlogix Appoints A. Brad Cann as Chief Financial Officer
2009 NOV 1 ... Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) ...
Subject: Therapy
Price: $3.00
*
Resverlogix Phase 1b/2a Study Meets Primary Endpoint
2009 SEP 7 ... Resverlogix Corp. (TSX:RVX) is pleased to announce several quarterly updates. The Phase 1b/2a study ...
Subject: Cardiovascular Disease
Price: $3.00
*
Resverlogix Provides Quarterly Update
2009 MAY 11 ... Resverlogix Corp. ("Resverlogix" or "Company") ...
Subject: Clinical Trial Research
Price: $3.00
*
Resverlogix RVX-208 Second Clinical Trial Demonstrates Success on Key Reverse Cholesterol Transport Markers
2009 OCT 12 ... Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) ...
Subject: Resverlogix Corp.
Price: $3.00
*
Resverlogix Updates Shareholders on Accelerated Clinical Trial Plan
2009 NOV 1 ... Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) ...
Subject: Clinical Trial Research
Price: $3.00
*
Resverlogix's Success in Inflammation Program Results in 2 Patents Filed
2009 JUN 1 ... Resverlogix Corp. ("Resverlogix" or the "Company") ...
Subject: Arthritis
Price: $3.00
*
ApoA-I Data Presented at European Society of Cardiology Congress
2008 SEP 15 ... Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) is ...
Subject: Resverlogix Corp.
Price: $3.00
*
Industry Leaders Select Resverlogix's RVX-208
2008 JUL 21 ... Resverlogix Corp's ("Resverlogix" or the "Company") (TSX:RVX) ...
Subject: Cardiovascular Disease
Price: $3.00
*
Industry Leaders Select Resverlogix's RVX-208 Among Top 10 Most Promising Drugs
2008 JUL 21 ... Resverlogix Corp's ("Resverlogix" or the "Company") (TSX:RVX) ...
Subject: Resverlogix Corp.
Price: $3.00
*
International Steering Committee for RVX-208 IVUS Trial Formed
2008 OCT 20 ... Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) is ...
Subject: Resverlogix Corp.
Price: $3.00
*
Jan Gray Joins Resverlogix Board of Directors
2008 AUG 11 ... Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) is ...
Subject: Life Sciences
Price: $3.00
*
Phase 1b/2a Program Commences for RVX-208
2008 SEP 8 ... Resverlogix Corp. ("Resverlogix" or the "Company") (TSX: RVX) ...
Subject: Resverlogix Corp.
Price: $3.00
*
Resverlogix Advances to Second Arm of Phase 1b/2a Clinical Trial
2008 NOV 3 ... Resverlogix Corp. ("Resverlogix") (TSX:RVX) announced that the ...
Subject: Resverlogix Corp.
Price: $3.00
*
Resverlogix Announces Closing of Debt Redemption
2008 NOV 5 ... Resverlogix Corp. ("Resverlogix") (TSX:RVX) announced that the ...
Subject: Resverlogix Corp.
Price: $3.00
*
Resverlogix Board of Directors Update
2008 DEC 9 ... Resverlogix Corp. ("Resverlogix") (TSX:RVX) announced that the ...
Subject: Resverlogix Corp.
Price: $3.00
*
Resverlogix Eliminates Sixty Percent of Remaining Debt
2008 OCT 28 ... Resverlogix Corp. ("Resverlogix") (TSX:RVX) announced that it has ...
Subject: Resverlogix Corp.
Price: $3.00
*
Resverlogix's Lead Drug Featured in Key Scientific Publication
2008 AUG 4 ... Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) is ...
Subject: Resverlogix Corp.
Price: $3.00
*
RVX-208 Exploratory Study Illustrates Early Potential for Alzheimer's Disease
2008 NOV 24 ... Resverlogix Corp. ("Resverlogix") (TSX:RVX) announced that ...
Subject: Alzheimer Disease
Price: $3.00
*

Results 1 - 20      Next >

-----------------------
Home | Free Newsletters | Products | Article Library | About Us | Contact | Privacy Policy | Search | Visit VerticalNews.com
Copyright © 2009 NewsRx		 PR Login